Conduit Pharmaceuticals Profit Margin

Conduit Pharmaceuticals (CDT) currently reports a profit margin of 12.85% as of June 2026. That compares with 6.29% in the prior-year period — up 104.5% year over year. That is below the sector sector average of 21.59%. Use the charts on this page to explore Conduit Pharmaceuticals's profit margin history and peer comparisons.

Conduit Pharmaceuticals's profit margin increased from 6.29% to 12.85% — a 104.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Conduit Pharmaceuticals's profit margin of 12.85% is lower than the its sector sector average of 21.59%. That is roughly 40.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Conduit Pharmaceuticals's current 12.85% should be judged against industry norms (sector average: 21.59%) and against CDT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 12.85%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 21.59%. From there, open related valuation or income-statement pages for Conduit Pharmaceuticals, and consider following CDT for alerts when major investors trade the stock.